UK markets close in 3 hours 6 minutes

Raphael Pharmaceutical Inc. (RAPH)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
1.54000.0000 (0.00%)
At close: 11:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 30.60M
Enterprise value 30.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)304.45
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.01

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 313.10%
S&P500 52-week change 325.22%
52-week high 31.6700
52-week low 30.6000
50-day moving average 31.2656
200-day moving average 31.0671

Share statistics

Avg vol (3-month) 345
Avg vol (10-day) 3N/A
Shares outstanding 518.66M
Implied shares outstanding 618.66M
Float 814.85M
% held by insiders 151.46%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-387.92%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-1.57M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)287k
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.77
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-976k
Levered free cash flow (ttm)-432.62k